A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice
- 28 February 2005
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 166 (2) , 477-489
- https://doi.org/10.1016/s0002-9440(10)62270-5
Abstract
No abstract availableKeywords
Funding Information
- Association Française contre les Myopathies
This publication has 55 references indexed in Scilit:
- Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosisThe FASEB Journal, 2004
- Decrease in resting calcium and calcium entry associated with slow‐to‐fast transition in unloaded rat soleus muscleThe FASEB Journal, 2003
- A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor–regulated channelThe Journal of cell biology, 2003
- Calcineurin activates NF-κB in skeletal muscle C2C12 cellsCellular Signalling, 2003
- Identification of the Δ-6 Desaturase of Human Sebaceous Glands: Expression and Enzyme ActivityJournal of Investigative Dermatology, 2003
- Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuseBrain, 2002
- Progression of dystrophic features and activation of mitogen‐activated protein kinases and calcineurin by physical exercise, in hearts of mdx miceFEBS Letters, 2002
- Helper (CD4+) and Cytotoxic (CD8+) T Cells Promote the Pathology of Dystrophin-Deficient MuscleClinical Immunology, 2001
- Glucocorticoids and immunosup pressants do not change the prevalence of necrosis and regeneration in mdx skeletal musclesMuscle & Nerve, 1991
- A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice Immunological evidenceFEBS Letters, 1991